From Petri Dish to Human Trial
November 2nd, 2009 admin
Topics:
For many of us living with all forms of diabetes, hearing about extraordinary new prospects for treatment and a cure can become frustrating at the very least. For families who have to watch a loved one struggle to avoid complications, and through no fault of their own suffer from this disease, action cannot come fast enough!
Related Posts
Just a few days ago, the FDA gave it’s clearance for phase I/II human clinical trials evaluating Apha-1 Antitrypsin, also known as AAT in type 1 diabetics, based on the research of Dr. Eli Lewis and his team at Ben-Gurion University of the Negev.
Read More →
NOXXON Pharma AG announced that it has permission to commence a multiple ascending dose study of its Monocyte Chemoattractant Protein-1 (MCP-1) targeting anti-inflammatory Spiegelmer®, NOX-E36. NOXXON plans to develop NOX-E36 for the treatment of diabetic nephropathy and other diabetes related complications…
Read More →
I don’t write much about food choices. But believe me, as a person with diabetes (and gluten intolerance), I struggle with them all the time. We PWDs are used to hearing the “generic” nutritional suggestions from our dietitians and CDEs: don’t eat too much sugar, eat lots of veggies, drink water, etc. But what about
Read More →
Diabetes is becoming a major problem in the world and it is growing which is forcing the diabetes community to make some quick judgements: Prevent diabetes from ever occuring. Develop the cure to diabetes. Or take care of the people who have it in order to prevent complications. All three approaches are actively being pursued by the National Institutes...
Erectile dysfunction is one of the most prevalent diabetes-induced complications in men; current estimates suggest that as many as 75% of men with diabetes will develop some degree of ED, and in many cases diabetics develop more severe forms of ED that are less responsive to standard drugs…
Read More →
The growing problem of diabetes in Scotland is to be tackled by a new Scottish Government Action Plan launched this week. The Scottish Diabetes Action Plan sets out a course of action over the next three years which will support prevention and detection of diabetes and help improve NHS care throughout Scotland…
Read More →
Eating fast probably comes naturally to all of us. Hiking a long trail on my vacation in New Zealand a few days ago, I ate as quickly as I could when I stopped, because I wanted to get to the hut before dark. I ate for the energy that I needed to finish the hike, not for pleasure. For once, I wasn’t concerned about the taste of the food or eating...
With all the ways that we have now to treat fatty liver disease I don’t understand why any of us still have it. Yet most people with diabetes suffer from this potentially dangerous condition.Now we have yet another tool in our arsenal against fatty liver disease. It’s a strange one. Not strange as in being unfamiliar, but rather strange...
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This applies to adults as well as to children and adolescents…
Read More →
All of us feel sorry for ourselves once in a while. That goes double for those of us who have diabetes.We do have a serious disease that can be awfully hard on us. The complications of this disease are almost too much to even think about.But we aren’t alone. If you are as inquisitive as I am, you talk to lots of people who have diabetes. And...
Related Tweets from Twitter
Related News from Digg
Leave a comment
| Trackback
